C1 - Biospecimen Repository Core
C1 - 生物样本存储库核心
基本信息
- 批准号:7976119
- 负责人:
- 金额:$ 7.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsApoptosisArchivesAreaBiological AssayCell LineClinicalClinical DataCollectionComplementComplement component C1sCore FacilityDNADataDatabasesDiagnosisDideoxy Chain Termination DNA SequencingDrug resistanceEnrollmentEvaluationExcisionFibrosisFormalinFreezingGenotypeGoalsHousingHumanImageImmunohistochemistryIn SituIndividualLaboratoriesLesionMicroscopicMolecularMonitorMorphologyMusNecrosisNeedle biopsy procedureNormal tissue morphologyNucleic AcidsOncogenesParaffin EmbeddingPathologicPharmaceutical PreparationsPhosphotransferasesPilot ProjectsPlayPreparationProceduresProtocols documentationReproduction sporesResearchResearch PersonnelResearch Project GrantsResourcesRoleSamplingScanningSerumSoft Tissue NeoplasmsSpecimenSystemTissuesTumor Cell LineUpdateXenograft Modelchemotherapydesigndigitalhuman tissueoncologyperipheral bloodprogramsrepositoryresponsesarcomasoft tissuetumor
项目摘要
The Biospecimen Repository Core (CF-A) is designed to provide support to the basic translafional research
efforts of the SPORE. The Core will play a central role in collecfing, annotafing, storing, distribufing, and
tracking sarcoma and normal tissue blospecimens from pafients enrolled in research protocols. The four key
focus areas forthe sarcoma SPORE Biospecimen Repository are high quality banked fissue (frozen and
paraffin-embedded) and blood (serum and plasma); accurate and updated procedural, pathologic, and
clinical annotafion; efficient and effective distribufion of blospecimens for use in research protocols; and a
robust tracking system capable of monitoring blospecimens from collecfion through utilization. Integrating
these four components is a major goal of the Biospecimen Repository Core.
The Core will provide SPORE invesfigators with expert histopathologic evaluation of tumor samples, both
from pafients enrolled on research protocols and from murine and xenograft models. The Core will provide
assistance in performing and interprefing immunohistochemical studies, in selecfing fissue for
microdissecfion and construcfion of arrays, and in collaborating with project leaders and CF-B. The core will
also provide systematic assessment of tumor response to therapy in human tissues and in animal models of
sarcomas, including interpretafion of immunohistochemical markers for drug response, such as changes in
kinase phosphorylafion, inhibifion of proliferafion, and inducfion of apoptosis. The Core will provide
mutafional annotafion for sarcoma tumors and cell lines, as needed by individual research projects.
生物样本库核心(CF-A)旨在为基础转化研究提供支持
SPORE的努力。核心将在收集、注释、存储、分发和处理方面发挥核心作用。
跟踪参加研究方案的患者的肉瘤和正常组织样本。四个关键
肉瘤 SPORE 生物样本库的重点领域是高质量的储存组织(冷冻和
石蜡包埋)和血液(血清和血浆);准确和更新的程序、病理和
临床注释;高效且有效地分发用于研究方案的样本;和一个
强大的跟踪系统,能够监控样本从采集到使用的整个过程。整合
这四个组成部分是生物样本存储库核心的主要目标。
Core 将为 SPORE 研究人员提供肿瘤样本的专家组织病理学评估,包括
来自参加研究方案的患者以及小鼠和异种移植模型。核心将提供
协助进行和解释免疫组织化学研究,选择组织
显微切割和阵列构建,并与项目负责人和 CF-B 合作。核心将
还提供对人体组织和动物模型中肿瘤治疗反应的系统评估
肉瘤,包括药物反应的免疫组织化学标记物的解释,例如
激酶磷酸化、增殖抑制和细胞凋亡诱导。核心将提供
根据个别研究项目的需要,对肉瘤肿瘤和细胞系进行突变注释。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRISTINA R ANTONESCU其他文献
CRISTINA R ANTONESCU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRISTINA R ANTONESCU', 18)}}的其他基金
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)
胃肠道间质瘤(GIST)的新疗法开发和耐药机制
- 批准号:
10932621 - 财政年份:2023
- 资助金额:
$ 7.59万 - 项目类别:
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)
胃肠道间质瘤(GIST)的新疗法开发和耐药机制
- 批准号:
10468962 - 财政年份:2018
- 资助金额:
$ 7.59万 - 项目类别:
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)
胃肠道间质瘤(GIST)的新疗法开发和耐药机制
- 批准号:
10016095 - 财政年份:2018
- 资助金额:
$ 7.59万 - 项目类别:
Novel therapeutics development and mechanisms of therapeutic resistance in gastrointestinal stromal tumor (GIST)
胃肠道间质瘤(GIST)的新疗法开发和耐药机制
- 批准号:
10247696 - 财政年份:2018
- 资助金额:
$ 7.59万 - 项目类别:
P1 - Molecular Mechanisms of KIT Signaling and Imatinib Resistance in GIST
P1 - GIST 中 KIT 信号传导和伊马替尼耐药的分子机制
- 批准号:
7976097 - 财政年份:2010
- 资助金额:
$ 7.59万 - 项目类别:
相似国自然基金
组织器官衰老致退行性演变多示踪剂全身动态PET显像研究
- 批准号:91949121
- 批准年份:2019
- 资助金额:68.0 万元
- 项目类别:重大研究计划
Slug参与CP-31398介导的p53突变型子宫内膜癌细胞凋亡的机制研究
- 批准号:81702967
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
N-甲基-N-亚硝脲诱导眼科疾病动物模型的潜能探索及治疗保护策略研究
- 批准号:81770887
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
Fascin-2基因TALEN敲除小鼠渐进性听力减退的机制研究
- 批准号:81771020
- 批准年份:2017
- 资助金额:54.0 万元
- 项目类别:面上项目
噪声介导COX2激活抑制Nrf2/ARE信号通路在促进耳蜗毛细胞死亡中的作用机制及干预研究
- 批准号:81600807
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Health Effects of the Fluorinated Pollutants; PFAS on Enamel Development
氟化污染物对健康的影响;
- 批准号:
10697298 - 财政年份:2023
- 资助金额:
$ 7.59万 - 项目类别:
Investigating the cellular and molecular mechanisms of lower-chlorinated polychlorinated biphenyl developmental neurotoxicity
研究低氯多氯联苯发育神经毒性的细胞和分子机制
- 批准号:
10678135 - 财政年份:2023
- 资助金额:
$ 7.59万 - 项目类别:
Targeting the microtubule cytoskeleton to promote cavernous nerve regeneration and erectile function after injury
靶向微管细胞骨架促进损伤后海绵体神经再生和勃起功能
- 批准号:
10719124 - 财政年份:2023
- 资助金额:
$ 7.59万 - 项目类别:
Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke
Kv2.1 靶向急性缺血性中风的一流神经保护疗法
- 批准号:
10598185 - 财政年份:2023
- 资助金额:
$ 7.59万 - 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
- 批准号:
10877239 - 财政年份:2023
- 资助金额:
$ 7.59万 - 项目类别: